Cantor Fitzgerald Reiterates Salesforce Rating, Initiates Milestone Pharmaceuticals Coverage

Cantor Fitzgerald has reiterated its stock rating for Salesforce, citing the company's AI potential, and initiated coverage of Milestone Pharmaceuticals with an overweight rating. These actions reflect the firm's assessment of both companies' market prospects.